Literature DB >> 21737156

Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk.

Irene Lambrinoudaki1, Eleni Armeni, Georgios Georgiopoulos, Maria Kazani, Evangelia Kouskouni, Maria Creatsa, Andreas Alexandrou, Stylianos Fotiou, Christos Papamichael, Kimon Stamatelopoulos.   

Abstract

BACKGROUND: The menopausal status is closely related with cardiovascular disease (CVD). Nevertheless, it is still not included in risk stratification by total cardiovascular risk estimation systems. The present study aimed to evaluate the extent of subclinical vascular disorders in young healthy postmenopausal women.
METHODS: This cross-sectional study consecutively recruited 120 healthy postmenopausal women without clinically overt CVD or diabetes, aged 41-60 years and classified as not high-risk by the Heartscore (<5%). In addition to risk factors used for Heartscore calculations, years since menopause and associated risk factors (triglycerides (range 37-278 mg/dl), waist circumference (62-114 cm), fasting blood glucose (69-114 mg/dl) and HOMA-IR (0.44-5)) were also assessed. Carotid-femoral pulse wave velocity, carotid and femoral intima-media thickness in the abnormal range as well as atheromatous plaques both in carotid and femoral arteries were used to define the presence of subclinical atherosclerosis.
RESULTS: Subclinical atherosclerosis and the presence of at least one plaque were identified in 55% and 28% of women, respectively. Subjects with subclinical atherosclerosis had higher age, years since menopause, HOMA-IR and blood pressure. By multivariate analysis years since menopause and systolic blood pressure independently determined subclinical atherosclerosis while 79% of intermediate-risk women (Heartscore 2-4.9%) being in menopause for at least 4 years would be reclassified to a higher risk for the presence of atherosclerosis.
CONCLUSION: Subclinical atherosclerosis was highly prevalent in postmenopausal women with low to medium Heartscore. Thus our data suggest that menopausal status and associated risk factors should be additionally weighted in risk calculations, regarding primary prevention strategies in this population.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21737156     DOI: 10.1016/j.ijcard.2011.06.063

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; Karol E Watson; David C Goff; David A Bluemke; Preethi Srikanthan; Tamara Horwich; Alain G Bertoni
Journal:  Menopause       Date:  2015-05       Impact factor: 2.953

2.  High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.

Authors:  Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-20       Impact factor: 2.357

3.  The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome.

Authors:  Eliana A P Nahas; Jorge Nahas-Neto; Claudio L Orsatti; Ana Paula Tardivo; Gilberto Uemura; Maria Terezinha S Peraçoli; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2013-12-11       Impact factor: 3.667

4.  Follicle-stimulating hormone, but not cardiorespiratory fitness, is associated with flow-mediated dilation with advancing menopausal stage.

Authors:  Corinna Serviente; Sarah Witkowski
Journal:  Menopause       Date:  2019-05       Impact factor: 2.953

5.  Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; Karol E Watson; David C Goff; David A Bluemke; Preethi Srikanthan; Tamara Horwich; Alain G Bertoni
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

6.  Osteoporosis Is Associated With High Risk for Coronary Heart Disease: A Population-Based Cohort Study.

Authors:  Sy-Jou Chen; Chin-Sheng Lin; Cheng-Li Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

7.  Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women.

Authors:  Ramon Bossardi Ramos; Vitor Fabris; Sheila Bunecker Lecke; Maria Augusta Maturana; Poli Mara Spritzer
Journal:  BMC Med Genet       Date:  2016-10-10       Impact factor: 2.103

8.  Pregnancy-related events associated with subclinical cardiovascular disease burden in late midlife: SWAN.

Authors:  Yamnia I Cortés; Janet M Catov; Maria Brooks; Samar R El Khoudary; Rebecca C Thurston; Karen A Matthews; Carmen R Isasi; Elizabeth A Jackson; Emma Barinas-Mitchell
Journal:  Atherosclerosis       Date:  2019-07-30       Impact factor: 5.162

9.  Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women.

Authors:  Gökçe Anık İlhan; Begüm Yıldızhan
Journal:  Turk J Obstet Gynecol       Date:  2019-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.